| HGNC Family | Non-coding RNAs |
| Name | microRNA 6125 |
| Description | microRNAs (miRNAs) are short (20-24 nt) non-coding RNAs that are involved in post-transcriptional regulation of gene expression in multicellular organisms by affecting both the stability and translation of mRNAs. miRNAs are transcribed by RNA polymerase II as part of capped and polyadenylated primary transcripts (pri-miRNAs) that can be either protein-coding or non-coding. The primary transcript is cleaved by the Drosha ribonuclease III enzyme to produce an approximately 70-nt stem-loop precursor miRNA (pre-miRNA), which is further cleaved by the cytoplasmic Dicer ribonuclease to generate the mature miRNA and antisense miRNA star (miRNA*) products. The mature miRNA is incorporated into a RNA-induced silencing complex (RISC), which recognizes target mRNAs through imperfect base pairing with the miRNA and most commonly results in translational inhibition or destabilization of the target mRNA. The RefSeq represents the predicted microRNA stem-loop. [provided by RefSeq, Sep 2009] |
| Summary |
{"type": "root", "children": [{"type": "p", "children": [{"type": "t", "text": "\nRecent studies have underscored the urgent need for reliable biomarkers to predict cisplatināinduced nephrotoxicity in cancer patients, as no such marker is currently available."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "1"}]}, {"type": "t", "text": " \n"}]}, {"type": "t", "text": "\n\n"}, {"type": "p", "children": [{"type": "t", "text": "\nEmerging evidence points to the microRNA MIR6125 as a potential candidate in filling this critical gap. Although its precise mechanism remains to be fully elucidated, MIR6125 appears to modulate key gene expression pathways that may influence kidney cell responses to cisplatin, thereby impacting the susceptibility to nephrotoxic injury."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "1"}]}, {"type": "t", "text": "\n"}]}, {"type": "t", "text": "\n\n"}, {"type": "p", "children": [{"type": "t", "text": "\nThese findings suggest that MIR6125 could serve as a prognostic biomarker for identifying patients at elevated risk for cisplatin-induced renal toxicity. Future research is warranted to validate its functional role and assess its clinical utility in guiding personalized therapeutic strategies and minimizing renal damage."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "1"}]}, {"type": "t", "text": "\n"}]}, {"type": "rg", "children": [{"type": "r", "ref": 1, "children": [{"type": "t", "text": "Julia C F Quintanilha, Maria A Cursino, Jessica B Borges, et al. "}, {"type": "b", "children": [{"type": "t", "text": "MiR-3168, miR-6125, and miR-4718 as potential predictors of cisplatin-induced nephrotoxicity in patients with head and neck cancer."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "BMC Cancer (2021)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1186/s12885-021-08317-2"}], "href": "https://doi.org/10.1186/s12885-021-08317-2"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "34011306"}], "href": "https://pubmed.ncbi.nlm.nih.gov/34011306"}]}]}]}
|
| Synonyms | HSA-MIR-6125, MIR-6125 |
| NCBI Gene ID | 102465133 |
| API | |
| Download Associations | |
| Predicted Functions |
![]() |
| Co-expressed Genes |
![]() |
| Expression in Tissues and Cell Lines |
![]() |
MIR6125 has 0 functional associations with biological entities spanning 0 categories () extracted from 0 datasets.
Click the + buttons to view associations for MIR6125 from the datasets below.
If available, associations are ranked by standardized value
| Dataset | Summary |
|---|